|1.||Macdougall, Iain C: 5 articles (04/2014 - 08/2005)|
|2.||Muñoz, Manuel: 5 articles (04/2012 - 10/2004)|
|3.||Huch, R: 5 articles (04/2007 - 08/2000)|
|4.||Fukumoto, Seiji: 4 articles (07/2015 - 10/2009)|
|5.||Agarwal, Rajiv: 4 articles (01/2011 - 09/2004)|
|6.||Breymann, C: 4 articles (11/2002 - 08/2000)|
|7.||Brookhart, M Alan: 3 articles (01/2016 - 06/2013)|
|8.||Winkelmayer, Wolfgang C: 3 articles (01/2016 - 06/2013)|
|9.||Goldenberg, Hans: 3 articles (03/2015 - 06/2003)|
|10.||Scheiber-Mojdehkar, Barbara: 3 articles (03/2015 - 06/2003)|
07/01/2008 - "Efficacy of intravenous iron sucrose administration for correcting preoperative anemia in patients scheduled for major orthopedic surgery."
02/01/2013 - "Intravenous administration of iron sucrose is a safe treatment for correction of anemia in pregnancy, without serious side-effects."
01/01/2005 - "Iron sucrose, given weekly as 200 mg IV push over 5 min is an effective and safe anemia treatment in this population."
03/07/2009 - "We evaluated the efficacy of intravenous iron sucrose (IVIS) administration for correction of anemia in these patient populations. "
01/01/1998 - "She was intravenously treated by saccharated ferric oxide and her anemia was improved, but her bone marrow still showed much gelatinous material."
|2.||Iron-Deficiency Anemia (Anemia, Iron Deficiency)
06/01/2012 - "Intravenous Iron sucrose is a safe and effective treatment for the rapid reversal of iron deficiency anemia, in obstetric and gynecological settings."
04/01/2014 - "Two 750-mg infusions of FCM are a safe and effective alternative to multiple lower dose iron sucrose infusions in NDD-CKD patients with iron-deficiency anemia."
03/01/2007 - "There is no apparent difference in the safety and efficacy of iron sucrose between elder and younger adults in the treatment of iron-deficiency anemia in HDD patients with CKD."
06/01/2012 - "The present study was undertaken to assess the impact of intravenous iron sucrose (Feronia IV) in the treatment of iron deficiency anemia observed in gynecological and obstetrical practice. "
08/01/2004 - "The aim of the present study was to evaluate the safety and tolerability of intravenous high-dose iron sucrose therapy specifically in patients with iron deficiency anemia (IDA) due to gastrointestinal blood loss. "
|3.||Kidney Diseases (Kidney Disease)
11/01/2003 - "The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease."
12/01/2002 - "The efficacy of iron sucrose has been shown in patients with chronic kidney disease (CKD) both before and after the initiation of dialysis therapy. "
05/01/2006 - "Intravenous iron sucrose is an effective adjunct to ESA therapy in anemic patients with PD-dependent chronic kidney disease and is administered safely as 300 mg over 1.5 h or 400 mg over 2.5 h. "
04/15/2006 - "The safety of high-dose iron sucrose infusion in hospitalized patients with chronic kidney disease was studied. "
04/15/2006 - "Safety of high-dose iron sucrose infusion in hospitalized patients with chronic kidney disease."
02/01/2012 - "Comparison of oxidative stress and inflammation induced by different intravenous iron sucrose similar preparations in a rat model."
07/01/2011 - "In this study, we developed four experimental iron overload models in young rats using iron sucrose and evaluated different markers of iron overload, tissue oxidative stress and inflammation as its consequences. "
05/01/2004 - "Anaemia associated with IBD can be successfully treated with intravenously administered iron sucrose, provided that bowel inflammation is treated adequately and enough iron is given. "
07/01/2011 - "The present results suggest a correlation between iron overload levels and the dose of iron, as well as the duration and frequency of iron injection and confirm that iron sucrose may not play a crucial role in inflammation and oxidative stress. "
01/01/2015 - "A cohort of 212 hemodialysis patients free of overt inflammation or malnutrition, were treated for anemia with parenteral iron-sucrose and an erythropoesis-stimulating agent, in keeping with current clinical guidelines. "
11/01/1989 - "In nine of the 19 rats treated with ferric saccharate, mesothelial tumors were induced in the serosa of the tunica vaginalis or the length of the spermatic cord. "
04/01/2007 - "Therefore, intravenously administered iron sucrose would be effective in the prevention of anemia of cervical cancer patients receiving concurrent chemoradiotherapy."
04/01/2007 - "The aim of this study was to examine the impact of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients undergoing concurrent chemoradiotherapy. "
04/01/2007 - "Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy."
07/01/1981 - "(1) The uptake of 67Ga in the tumor and soft-tissues except bone was decreased compared with controls if the concentration of serum iron was elevated by Fesin (saccharated ferric oxide) administered prior the injection of 67Ga. "
|5.||ferric gluconate (Ferrlecit)
|8.||iron(III)-hydroxide sucrose complex
|10.||Vitamin B 12 (Cyanocobalamin)
|1.||Renal Dialysis (Hemodialysis)
|2.||Gynecologic Surgical Procedures (Gynecologic Surgery)
|4.||Blood Transfusion (Blood Transfusions)